SAEDNEWS: A personalized smart lung cancer vaccine using mRNA and AI can now be designed in 2–3 weeks, enabling precise prevention and treatment for patients.
Revolutionary AI-Powered Cancer Vaccine Developed by Tehran Scientist Promises Faster, Personalized Lung Cancer Prevention
Dr. Mohammad Hossein Yazdi, head of the Biotechnology Research Center at Tehran University of Medical Sciences and a pharmacy faculty member, has pioneered a breakthrough in personalized and intelligent cancer vaccines.
This cutting-edge vaccine leverages patients’ tumor genetic profiles and advanced AI algorithms to predict the most effective formulation, drastically reducing the trial-and-error process typical of traditional vaccines. The innovation accelerates development by nearly 90%, allowing design and preparation in just 2–3 weeks.
Dr. Yazdi highlights that this approach not only provides a targeted treatment for lung cancer patients but also serves as a preventive measure for high-risk individuals, potentially transforming the landscape of cancer care and prevention worldwide.
